Effect of bolus injection versus continuous infusion of furosemide on diuresis and neurohormonal activation in patients with severe congestive heart failure
- 1 January 1997
- journal article
- research article
- Published by Taylor & Francis in Scandinavian Journal of Clinical and Laboratory Investigation
- Vol. 57 (4) , 361-367
- https://doi.org/10.3109/00365519709099409
Abstract
Previous studies have demonstrated that continuous infusion of furosemide results in increased diuresis and natriuresis compared with bolus administration of the drug in patients with severe heart failure. We reasoned that continuous infusion of furosemide caused less activation of neurohumoral mechanisms, since other studies have shown that bolus administration of furosemide may activate this system. We therefore tested the hypothesis that continuous administration of furosemide would increase water and sodium excretion due to less activation of neurohormones. Eight patients with severe heart failure were studied during continuous infusion over 24 h and bolus injections of furosemide twice daily in a randomized cross-over study. Bolus administration of furosemide increased diuresis and natriuresis significantly in the first 4 h after administration compared with continuous administration, but this was later reversed, resulting in similar 24 h total output. The neurohormones measured at baseline were all markedly elevated. Neither regimens of furosemide caused any further significant changes in neurohumoral response except that pro-ANF decreased more during the first 8 h after bolus administration compared to continuous infusion. This study has demonstrated that bolus administration of furosemide in conventional doses is equally effective as continuous intravenous infusion in patients with severe heart failure. This may be due to maximal neurohormonal activation in severe heart failure (NYHA III-IV) which could not be further activated by bolus administration.Keywords
This publication has 20 references indexed in Scilit:
- Increased Plasma Concentrations of Endothelin in Congestive Heart Failure in HumansMayo Clinic Proceedings, 1992
- Plasma endothelin in chronic heart failure.Circulation, 1992
- Haemodynamic and neurohumoral effects of cold pressor test in severe heart failureClinical Physiology and Functional Imaging, 1992
- Prognostic importance of atrial natriuretic peptide in patients with chronic heart failureJournal of the American College of Cardiology, 1989
- Plasma neuropeptide Y‐like immunoreactivity and catecholamines during various degrees of sympathetic activation in manClinical Physiology and Functional Imaging, 1986
- Contribution of vasopressin to vasoconstriction in patients with congestive heart failure: Comparison with the renin-angiotensin system and the sympathetic nervous systemJournal of the American College of Cardiology, 1986
- Plasma Norepinephrine as a Guide to Prognosis in Patients with Chronic Congestive Heart FailureNew England Journal of Medicine, 1984
- The Neurohumoral Axis in Congestive Heart FailureAnnals of Internal Medicine, 1984
- Alterations in vasomotor tone in congestive heart failureProgress in Cardiovascular Diseases, 1982
- Plasma norepinephrine as an indicator of sympathetic neural activity in clinical cardiologyThe American Journal of Cardiology, 1981